(Boursier.com) — The company OSE Immunotherapeutics announced the appointment of Dr. Nicolas Poirier as the new Chief Executive Officer as of this Friday. This appointment follows the decision of the Board of Directors to end the mandate of Alexis Vandier.
OSE points out that Nicolas Poirier played a decisive role in its development, notably at the origin of 5 programs in the company’s portfolio which are now at the clinical stage. He also strongly contributed to the signing of 4 strategic pharmaceutical partnerships for OSE Immunotherapeutics.
Nicolas Poirier is a Doctor of Sciences in Immunology (European Center for Transplantation and Immunotherapy Sciences, Nantes), graduated from a double master’s degree in Biotechnology at the University of Nantes and in Pharmacology at the Louis Pasteur University of Strasbourg and a degree in “Global Management” from INSEAD. He has been Scientific Director and member of the management team of OSE Immunotherapeutics since 2016.
©2022 Boursier.com